Description / Application
Fulvestrant is a 3-hydroxy steroid that is 17beta-estradiol in which the 7alpha hydrogen has been replaced by a nonyl group in which one of the hydrogens of the terminal methyl has been replaced by a (4,4,5,5,5-pentafluoropentyl)sulfinyl group. An estrogen receptor antagonist, it is used in the treatment of breast cancer. It has a role as an antineoplastic agent, an estrogen receptor antagonist and an estrogen antagonist. It is a sulfoxide, a 17beta-hydroxy steroid, a 3-hydroxy steroid and an organofluorine compound. It derives from a hydride of an estrane.
Identities
| Alternative Name | (7a,17b)-7-[9-[(4,4,5,5,5pentafluoropentyl)Sulfinyl]nonyl]estra-1,3,5(10)-triene-3,17-diol; Faslodex |
|---|---|
| Molecular Formula | C32H47F5O3S |
| Molecular Weight | 606.8 |
| MFCD | MFCD00903953 |
Safety
| Pictograms |
|
|---|---|
| Signal Word | Danger |
| Hazard Statements | H315;H319;H335;H360;H362;H410 |
| Precautionary Statements | P261;P264;P271;P280;P302+P352;P304+P340;P305+P351+P338;P312;P321;P332+P313;P337+P313;P362;P403+P233;P405;P501 |